Olaris CEO sits on panel, "The Evolving Role of Biomarkers and Diagnostics"

Olaris CEO, Dr. Liz O'Day, sits on a panel at the Cancer Advance Conference to discuss how biomarkers and diagnostics are changing how we treat cancer.